Skip to content

Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors

Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01602094
Enrollment
550
Registered
2012-05-18
Start date
2012-07-31
Completion date
2013-03-31
Last updated
2012-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measles

Keywords

measles, antibody, prevalence, predictors, Donor of National Blood Centre, The Thai Red Cross Society who age 18-30 years old, Measles antibody levels, Predictors of adequate measles antibody levels and inadequate measles antibody levels

Brief summary

Prevalence of participants who have protective immunity to measles virus is less than ninety percent. Predictor of adequate measles antibody levels include the following : * History of measles infection * History of complete measles primary immunization( 2 doses with at least 1 month interval after age of 9 months) * History of measles exposure Predictor of inadequate measles antibody levels include the following : * Born outside Thailand * History of staying outside Thailand for long time in childhood * Living in the rural area for a long period in childhood * Fail to participate school system on time

Interventions

None listed

Sponsors

Queen Saovabha Memorial Institute
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18-30 years old

Exclusion criteria

* Last measles vaccination less than 10 years of age * Immunocompromised host including congenital immune defect, splenectomy or splenic dysfunction, history of suspect HIV exposure, taking immunosuppressant * Receiving blood or blood product within 3 months * Receiving others vaccinations or immunoglobulins or any medication that possibly decrease immune response

Countries

Thailand

Contacts

Primary ContactJaruboot Angsanakul, M.D.
jaruboot@yahoo.com662-252-0161-4

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026